The exceptionally low capital allocation score of 25/100 is a significant concern for Kenvue, indicating fundamental challenges in deploying capital effectively to drive shareholder value.
While the company generates substantial TTM Free Cash Flow of $2.68B and maintains an impressively low Debt/Equity ratio of 0.18x, these financial strengths do not appear to be translated into strategic growth. The most direct evidence of ineffective capital allocation is the anemic 3-year revenue CAGR of just 0.1%.
This suggests a failure to invest in areas that could stimulate top-line expansion, whether through innovative product development, strategic acquisitions, or market penetration initiatives.
Despite a high TTM ROE of 27.7%, this metric needs to be viewed cautiously, as it might reflect returns generated within a static or contracting revenue base rather than from effective investments in sustainable growth opportunities, raising questions about management's long-term strategic vision.







